FDA — authorised 9 May 1997
- Application: NDA020617
- Marketing authorisation holder: AVENT
- Local brand name: PYTEST
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Pytest in United States
FDA authorised Pytest on 9 May 1997
Marketing authorisations
FDA
- Status: approved
Pytest in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Pytest approved in United States?
Yes. FDA authorised it on 9 May 1997; FDA has authorised it.
Who is the marketing authorisation holder for Pytest in United States?
AVENT holds the US marketing authorisation.